Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function

European Journal of Immunology

Volumn 43, Issue 9, 2013, Pages 2409-2420

  Dintwe, One B ^a   Day, Cheryl L ^a,b,c   Smit, Erica ^a   Nemes, Elisa ^a   Gray, Clive ^d   Tameris, Michele ^a   Mcshane, Helen ^e   Mahomed, Hassan ^a   Hanekom, Willem A ^a   Scriba, Thomas J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

HLA class II tetramer; MVA85A; Proliferation; T cells; Vaccine

Indexed keywords

BCG VACCINE; CD27 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTEGRIN; INTERLEUKIN 2; TETRAMER;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELL HOMING; CHILD; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE FUNCTION; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; TUBERCULOSIS;

HLA CLASS II TETRAMER; MVA85A; PROLIFERATION; T CELLS; VACCINE;

ACYLTRANSFERASES; ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD27; ANTIGENS, CD38; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CCR7; TUBERCULOSIS; TUBERCULOSIS VACCINES; VIRAL VACCINES; YOUNG ADULT;

EID: 84883509055     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343454     Document Type: Article

References (52)

1. Plotkin, S. A. O. W., Vaccines, 3rd ed. Saunders, Philadelphia, PA, 1999.
2. Kaufmann, S. H. and McMichael, A. J., Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat. Med. 2005. 11: S33-S44.
3. Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J. and Zumla, A., Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 2011. 11: 343-354.
4. Kaufmann, S. H., Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 2010. 33: 567-577.
5. Lambert, P. H., Hawkridge, T. and Hanekom, W. A., New vaccines against tuberculosis. Clin. Chest Med. 2009. 30: 811-826.
6. Hatherill, M., Prospects for elimination of childhood tuberculosis: the role of new vaccines. Arch. Dis. Child 2011. 96: 851-856.
7. Hanekom, W. A., Dockrell, H. M., Ottenhoff, T. H., Doherty, T. M., Fletcher, H., McShane, H., Weichold, F. F. et al., Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med. 2008. 5: e145.
8. Abel, B., Tameris, M., Mansoor, N., Gelderbloem, S., Hughes, J., Abrahams, D., Makhethe, L. et al., The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am. J. Respir. Crit. Care Med. 2010. 181: 1407-1417.
9. Soares, A. P., Scriba, T. J., Joseph, S., Harbacheuski, R., Murray, R. A., Gelderbloem, S. J., Hawkridge, A. et al., Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 2008. 180: 3569-3577.
10. Tameris, M. D., Hatherill, M., Landry, B. S., Scriba, T. J., Snowden, M. A., Lockhart, S., Shea, J. E. et al., Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013. 381: 1021-1028.
11. Esser, M. T., Marchese, R. D., Kierstead, L. S., Tussey, L. G., Wang, F., Chirmule, N. and Washabaugh, M. W., Memory T cells and vaccines. Vaccine 2003. 21: 419-430.
12. Scriba, T. J., Tameris, M., Mansoor, N., Smit, E., van der Merwe, L., Mauff, K., Hughes, E. J. et al., Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J. Infect. Dis. 2011. 203: 1832-1843.
13. Scriba, T. J., Tameris, M., Smit, E., van der Merwe, L., Hughes, E. J., Kadira, B., Mauff, K. et al., A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am. J. Respir. Crit. Care Med. 2012. 185: 769-778.
14. Chao, C. C., Jensen, R. and Dailey, M. O., Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 1997. 159: 1686-1694.
15. Sallusto, F., Geginat, J. and Lanzavecchia, A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004. 22: 745-763.
16. Vallejo, A. N., Brandes, J. C., Weyand, C. M. and Goronzy, J. J., Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J. Immunol. 1999. 162: 6572-6579.
17. Malcherek, G., Falk, K., Rotzschke, O., Rammensee, H. G., Stevanovic, S., Gnau, V., Jung, G. et al., Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 1993. 5: 1229-1237.
18. Scriba, T. J., Tameris, M., Mansoor, N., Smit, E., van der Merwe, L., Isaacs, F., Keyser, A. et al., Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur. J. Immunol. 2010. 40: 279-290.
19. Hawkridge, T., Scriba, T. J., Gelderbloem, S., Smit, E., Tameris, M., Moyo, S., Lang, T. et al., Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J. Infect. Dis. 2008. 198: 544-552.
20. Campbell, D. J. and Butcher, E. C., Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 2002. 195: 135-141.
21. Kantele, A., Zivny, J., Hakkinen, M., Elson, C. O. and Mestecky, J., Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J. Immunol. 1999. 162: 5173-5177.
22. Walrath, J. R. and Silver, R. F., The {alpha}4{beta}1 integrin in localization of Mycobacterium tuberculosis-specific Th1 cells to the human lung. Am. J. Respir. Cell Mol. Biol. 2011. 45: 24-30.
23. Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L. and Ahmed, R., Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 2003. 171: 4969-4973.
24. Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K. et al., Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008. 28: 710-722.
25. Akondy, R. S., Monson, N. D., Miller, J. D., Edupuganti, S., Teuwen, D., Wu, H., Quyyumi, F. et al., The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J. Immunol. 2009. 183: 7919-7930.
26. Wrammert, J., Miller, J., Akondy, R. and Ahmed, R., Human immune memory to yellow fever and smallpox vaccination. J. Clin. Immunol. 2009. 29: 151-157.
27. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
28. Sallusto, F., Langenkamp, A., Geginat, J. and Lanzavecchia, A., Functional subsets of memory T cells identified by CCR7 expression. Curr. Top Microbiol. Immunol. 2000. 251: 167-171.
29. Harari, A., Vallelian, F. and Pantaleo, G., Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 2004. 34: 3525-3533.
30. Zhang, Y., Joe, G., Hexner, E., Zhu, J. and Emerson, S. G., Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat. Med. 2005. 11: 1299-1305.
31. Gattinoni, L., Zhong, X. S., Palmer, D. C., Ji, Y., Hinrichs, C. S., Yu, Z., Wrzesinski, C. et al., Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 2009. 15: 808-813.
32. Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R. et al., A human memory T cell subset with stem cell-like properties. Nat. Med. 2011. 17: 1290-1297.
33. Geiger, R., Duhen, T., Lanzavecchia, A. and Sallusto, F., Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J. Exp. Med. 2009. 206: 1525-1534.
34. Kwok, W. W., Tan, V., Gillette, L., Littell, C. T., Soltis, M. A., LaFond, R. B., Yang, J. et al., Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire. J. Immunol. 2012. 188: 2537-2544.
35. Sutter, G. and Moss, B., Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 1992. 89: 10847-10851.
36. Burns, J. A., Issekutz, T. B., Yagita, H. and Issekutz, A. C., The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J. Immunol. 2001. 166: 4644-4649.
37. Masopust, D., Choo, D., Vezys, V., Wherry, E. J., Duraiswamy, J., Akondy, R., Wang, J. et al., Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 2010. 207: 553-564.
38. Fritsch, R. D., Shen, X., Sims, G. P., Hathcock, K. S., Hodes, R. J. and Lipsky, P. E., Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J. Immunol. 2005. 175: 6489-6497.
39. Orme, I. M., The Achilles heel of BCG. Tuberculosis (Edinb). 2010. 90: 329-332.
40. Cellerai, C., Harari, A., Vallelian, F., Boyman, O. and Pantaleo, G., Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization. Eur. J. Immunol. 2007. 37: 1129-1138.
41. Dye, C. and Fine, P. E., A major event for new tuberculosis vaccines. Lancet 2013. 381: 972-974.
42. Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N. et al., Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011. 473: 523-527.
43. Mittrucker, H. W., Steinhoff, U., Kohler, A., Krause, M., Lazar, D., Mex, P., Miekley, D. et al., Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Natl. Acad. Sci. USA 2007. 104: 12434-12439.
44. Kaveh, D. A., Bachy, V. S., Hewinson, R. G. and Hogarth, P. J., Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge. PLoS One 2011. 6: e21566.
45. Desel, C., Dorhoi, A., Bandermann, S., Grode, L., Eisele, B. and Kaufmann, S. H. E., Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J. Infect. Dis. 2011. 204: 1573-1584.
46. Hoft, D. F., Blazevic, A., Stanley, J., Landry, B., Sizemore, D., Kpamegan, E., Gearhart, J. et al., A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity. Vaccine 2012. 30: 2098-2108.
47. Tena-Coki, N. G., Scriba, T. J., Peteni, N., Eley, B., Wilkinson, R. J., Andersen, P., Hanekom, W. A. et al., CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am. J. Respir. Crit. Care Med. 2010. 182: 120-129.
48. Kagina, B. M., Abel, B., Bowmaker, M., Scriba, T. J., Gelderbloem, S., Smit, E., Erasmus, M. et al., Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 2009. 27: 5488-5495.
49. Caccamo, N., Meraviglia, S., La Mendola, C., Guggino, G., Dieli, F. and Salerno, A., Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol. 2006. 177: 1780-1785.
50. Soares, A., Govender, L., Hughes, J., Mavakla, W., de Kock, M., Barnard, C., Pienaar, B. et al., Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J. Immunol. Methods 2010. 362: 43-50.
51. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanovic, S., SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999. 50: 213-219.
52. Scriba, T. J., Purbhoo, M., Day, C. L., Robinson, N., Fidler, S., Fox, J., Weber, J. N. et al., Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining. J. Immunol. 2005. 175: 6334-6343.